Liquidia Corp. (LQDA)
28.64
+0.65
(+2.32%)
USD |
NASDAQ |
Oct 02, 16:00
28.49
-0.15
(-0.52%)
After-Hours: 20:00
Liquidia Market Cap : 2.552B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.552B |
| October 01, 2026 | 2.494B |
| September 30, 2026 | 2.696B |
| September 29, 2026 | 6.298B |
| September 28, 2026 | 6.564B |
| September 25, 2026 | 6.097B |
| September 24, 2026 | 6.322B |
| September 23, 2026 | 6.013B |
| September 22, 2026 | 6.116B |
| September 21, 2026 | 5.919B |
| September 18, 2026 | 5.959B |
| September 17, 2026 | 6.094B |
| September 16, 2026 | 6.099B |
| September 15, 2026 | 5.856B |
| September 14, 2026 | 5.819B |
| September 11, 2026 | 5.947B |
| September 10, 2026 | 6.045B |
| September 09, 2026 | 6.159B |
| September 08, 2026 | 6.030B |
| September 04, 2026 | 6.118B |
| September 03, 2026 | 6.115B |
| September 02, 2026 | 6.208B |
| September 01, 2026 | 5.962B |
| August 31, 2026 | 6.074B |
| August 28, 2026 | 6.031B |
| Date | Value |
|---|---|
| August 27, 2026 | 6.232B |
| August 26, 2026 | 6.358B |
| August 25, 2026 | 6.281B |
| August 24, 2026 | 6.261B |
| August 21, 2026 | 6.114B |
| August 20, 2026 | 6.331B |
| August 19, 2026 | 6.712B |
| August 18, 2026 | 6.623B |
| August 17, 2026 | 6.923B |
| August 14, 2026 | 6.633B |
| August 13, 2026 | 6.424B |
| August 12, 2026 | 7.020B |
| August 11, 2026 | 7.845B |
| August 10, 2026 | 8.111B |
| August 07, 2026 | 8.039B |
| August 06, 2026 | 7.897B |
| August 05, 2026 | 7.870B |
| August 04, 2026 | 7.805B |
| August 03, 2026 | 7.405B |
| July 31, 2026 | 7.428B |
| July 30, 2026 | 7.665B |
| July 29, 2026 | 7.667B |
| July 28, 2026 | 7.667B |
| July 27, 2026 | 7.455B |
| July 24, 2026 | 7.614B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Harmony Biosciences Holdings, Inc. | 2.304B |
| Johnson & Johnson | 616.58B |
| United Therapeutics Corp. | 23.12B |
| Amneal Pharmaceuticals, Inc. | 6.482B |
| Pfizer Inc. | 158.43B |
Market Cap Related Metrics
| PE Ratio | 20.99 |
| PS Ratio | 6.175 |
| Price to Book Value | 13.08 |
| Price to Free Cash Flow | 18.48 |
| Price | 28.64 |
| Earnings Yield | 4.76% |
| Operating PE Ratio | 16.52 |
| Normalized PE Ratio | 20.99 |